← Back to Search

Mobile App Voice Therapy for Transitioning Voice

N/A

Waitlist Available

Led By Anais Rameau, MD, MPhil

Research Sponsored by Weill Medical College of Cornell University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, week 4, week 11

Awards & highlights

No Placebo-Only Group

Summary

This trial will assess if an app can help transgender and gender diverse people improve their voice quality as much as traditional speech therapy.

Who is the study for?

This trial is for transgender and gender diverse individuals over 18 who own an iOS device and can read/write in English. It's not suitable for cisgender people or those with voice-related issues like hoarseness or pain.

What is being tested?

The study tests a mobile app called Attuned, designed to help with voice modification, against traditional in-person therapy. The effectiveness will be judged by participants' satisfaction with their voices and objective measures of voice quality.

What are the potential side effects?

Since this trial involves non-medical interventions (voice therapy via an app), side effects are minimal but may include temporary vocal strain or fatigue from practicing new speaking techniques.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, week 4, week 11

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, week 4, week 11

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 4, week 11 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Formants

Change in Fundamental Frequency

Change in Transgender Self Evaluation Questionnaire (TSEQ) Scores

+1 more

Secondary study objectives

Usability of Mobile Application as measured by the Mobile Application Rating Scale (MARS)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Transgender and gender diverse (TGGD) individuals using the pilot appExperimental Treatment1 Intervention

The investigators will develop Attuned, an open access voice and communication modification training (VCMT) app based on standard of care. Participants will undergo VCMT via the mobile application, Attuned. Participants will include healthy transgender and gender diverse (TGGD) individuals seeking voice modification to better reflect their identity.

Group II: Transgender and gender diverse (TGGD) individuals receiving standard voice modificationActive Control1 Intervention

VCMT via speech pathology will be compared to the efficacy of an app-based VCMT program. Participants will undergo VCMT in-person. Participants will include healthy transgender and gender diverse (TGGD) individuals seeking voice modification to better reflect their identity.

Do I qualify?Apply below to find out